Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

149 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cyclo Therapeutics : Corporate Presentation
PU
Cyclo Therapeutics : Corporate Presentation
PU
Tate & Lyle : Board changes - March 2024
PU
Tate & Lyle plc Appoints Jeffrey Carrwill as Non-Executive Director and as Member of the Audit and Nominations Committees on 1 April 2024
CI
Dow Inc. Announces Chief Financial Officer Changes
CI
Cyclo Therapeutics : Corporate Presentation
PU
Cyclo Therapeutics : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
HealthStream : 2022 Shareholder Letter
PU
LEGGETT & PLATT INC : Change in Directors or Principal Officers, Regulation FD Disclosure (form 8-K)
AQ
Leggett & Platt Announces Executive Changes
CI
Leggett & Platt Announces Chief Financial Officer Changes
CI
Transcript : HealthStream, Inc. - Shareholder/Analyst Call
HUNTINGTON BANCSHARES INC /MD/ : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
Transcript : Huntington Bancshares Incorporated - Shareholder/Analyst Call
Cyclo Therapeutics : Factsheet
PU
LEGGETT & PLATT INC : Change in Directors or Principal Officers (form 8-K)
AQ
LEGGETT & PLATT INC : Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (form 8-K)
AQ
LEGGETT & PLATT INC : Change in Directors or Principal Officers (form 8-K)
AQ
Transcript : Leggett & Platt, Incorporated, Q3 2022 Earnings Call, Nov 01, 2022
Cyclo Therapeutics : Factsheet
PU
© 2022 Tonix Pharmaceuticals Holding Corp. INVESTOR PRESENTATION NASDAQ: TNXP Version P0361 July 5, 2022 (Doc 1052) - Form 8-K
PU
Cyclo Therapeutics : Corporate Presentation
PU
CYCLO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
Prime Focus World N.V. cancelled the acquisition of Sports Ventures Acquisition Corp. from AKICV LLC, Empyrean Capital Overseas Master Fund, Ltd. managed by Empyrean Capital Partners, LP, Glazer Capital, LLC, HGC Investment Management Inc., Citadel Advisors LLC and others in a reverse merger transaction.
CI
Cyclo Therapeutics : Factsheet
PU
Cyclo Therapeutics : Factsheet
PU
Huntington Bancshares Incorporated : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
HUNTINGTON BANCSHARES INC /MD/ : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
AAON : Annual Report (Form ARS)
PU
Transcript : Kontrol Technologies Corp., Q4 2021 Earnings Call, Mar 31, 2022
CYCLO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
LEGGETT & PLATT INC : Change in Directors or Principal Officers (form 8-K)
AQ
Cyclo Therapeutics : CYTH Investor Presentation February 2022.pdf
PU
Artnet : After ‘Rigorous’ Review, Tate Has Concluded It Will Keep a Racist Mural on View, But Add a New Interpretation by a Contemporary Artist
PU
Prime Focus World N.V. entered into a entered into a letter of intent to acquire Sports Ventures Acquisition Corp. from AKICV LLC, Empyrean Capital Overseas Master Fund, Ltd. managed by Empyrean Capital Partners, LP, Glazer Capital, LLC, HGC Investment Management Inc., Citadel Advisors LLC and others for $1.3 billion in a reverse merger transaction.
CI
Cyclo Therapeutics : CYTH Investor Presentation January 22.pdf
PU
HealthStream : 2020 Annual Report
PU
HealthStream : 2019 Annual Report
PU
HealthStream : 2018 Annual Report
PU
HealthStream : 2017 Annual Report
PU
FREYR Signs Global SME Climate Commitment
PU
CYTH Investor Presentation November 2021[2].pdf
PU
CYTH Investor Presentation November 2021.pdf
PU
FREYR Battery : Further Strengthens Its Sustainability Team
PU
Transcript : DERMAdoctor, LLC., NovaBay Pharmaceuticals, Inc. - M&A Call
“Should Five Percent Appear Too Small, Be Thankful I Don’t Take It All”: Ways and Means Committee Advances Tax Increase and Reform Proposals
PU
CYCLO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Clearbit : Announces Derek Schlicker as New Chief Financial Officer
BU
Cyclo Therapeutics : Commences Commercial-Scale Manufacturing for Trappsol® Cyclo™
BU
Huntington Bancshares Incorporated : INC /MD/ Change in Directors or Principal Officers (form 8-K/A)
AQ
No results for this search
  1. Stock Market
  2. Advanced search
  3. Jeffrey Tate
  4. News